Related Experiment Video
Updated: May 28, 2026

Spinal Cord Neurons Isolation and Culture from Neonatal Mice
Published on: July 11, 2017
Magnesium sulfate does not protect spinal cord against ischemic injury
Jinyoung Hwang1, Jinhee Kim, Sanghyon Park
1Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Gyeonggi-do, Republic of Korea.
Objective:
We tested various doses of MgSO(4) to investigate the effect of Mg on a spinal cord ischemia.
Methods:
Rats were treated with either MgSO(4) (30, 100, or 300 mg/kg; group Mg(low), group Mg(medium), group Mg(high), respectively, n = 10 for each) or saline (control group; n = 10) before ischemia. Spinal cord ischemia was induced using a balloon-tipped catheter placed on proximal descending aorta. During surgery, hemodynamic variables were recorded before ischemia, during aortic occlusion and after reperfusion. Neurologic function was assessed using the motor deficit index (MDI; 0 = normal, 6 = complete paralysis) until seven days after reperfusion, and histologic examination of spinal cord was performed.
Results:
After reperfusion, the mean arterial pressure in the group Mg(high) was significantly lower than other groups. Compared to the control group, the groups Mg(low) and Mg(medium) did not show any difference in MDI and the group Mg(high) showed significantly higher MDI. The number of normal motor neurons was similar among other groups except the group Mg(high) had a significantly fewer normal motor neurons.
Conclusions:
Intravenous MgSO(4) with low or medium dose (30, or 100 mg/kg) did not improve neurological injury following spinal cord ischemia. Furthermore, higher dose of MgSO(4) (300 mg/kg) resulted in hemodynamic instability and aggravated neurologic outcome.
Insights
Low to medium doses of magnesium sulfate (MgSO(4)) did not improve outcomes for spinal cord ischemia in rats. Higher doses of MgSO(4) caused hemodynamic instability and worsened neurological deficits.
Area of Science:
- Neuroscience
- Pharmacology
- Ischemia Research
Background:
- Spinal cord ischemia is a critical condition with limited treatment options.
- Magnesium (Mg) has shown neuroprotective potential in various injury models.
- The efficacy of magnesium sulfate (MgSO(4)) in spinal cord ischemia requires further investigation.
Purpose of the Study:
- To evaluate the neuroprotective effects of different doses of magnesium sulfate (MgSO(4)) in a rat model of spinal cord ischemia.
- To determine the impact of varying MgSO(4) concentrations on neurological function and spinal cord histology post-ischemia.
Main Methods:
- Rats received intravenous MgSO(4) (30, 100, or 300 mg/kg) or saline (control) prior to inducing spinal cord ischemia.
- Hemodynamic variables were monitored throughout the procedure.
- Neurological function was assessed using the motor deficit index (MDI) for seven days, followed by histological examination.
Main Results:
- The high-dose MgSO(4) group (300 mg/kg) exhibited significantly lower mean arterial pressure post-reperfusion.
- Compared to controls, low and medium doses of MgSO(4) did not alter MDI scores.
- The high-dose MgSO(4) group showed a significantly higher MDI and fewer normal motor neurons, indicating worsened neurological outcome and neuronal damage.
Conclusions:
- Intravenous MgSO(4) at low (30 mg/kg) or medium (100 mg/kg) doses offers no benefit in mitigating neurological injury after spinal cord ischemia.
- A high dose of MgSO(4) (300 mg/kg) is detrimental, leading to hemodynamic instability and exacerbating neurological deficits and spinal cord damage.
Related Concept Videos
Secondary Spinal Cord Injury llI: Pathophysiology
Spinal Cord Injury ll: Pathophysiology
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Ischemic Stroke ll: Pathophysiology

